Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
14.11
+0.51 (3.74%)
Apr 13, 2026, 10:35 AM EDT - Market open
Apollomics Market Cap
Apollomics has a market cap or net worth of $30.29 million as of April 13, 2026. Its market cap has increased by 292.45% in one year.
Market Cap
30.29M
Enterprise Value
27.84M
1-Year Change
292.45%
Ranking
Category
Stock Price
$14.11
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $30.29M, a decrease of -76.62%. That is a compound annual growth rate of -28.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 29.20M | -27.22% |
| Dec 31, 2025 | 40.12M | 273.20% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 32.46M |
| Passage Bio | 31.73M |
| INmune Bio | 31.37M |
| BriaCell Therapeutics | 30.73M |
| Tempest Therapeutics | 29.41M |
| Marker Therapeutics | 29.18M |
| Kyntra Bio | 29.02M |
| IGC Pharma | 28.93M |